Under a new licensing deal, Qiagen will gain access to a big genetics database from Vienna-based Ares Genetics, which could help tackle the global health crisis of antibiotic resistance.
{iframe}https://labiotech.eu/medical/antibiotic-resistance-qiagen-ares/{/iframe}